Hemideina has raised funds via a private placement
Hemideina has raised US$7.4 million. The capital raised will be used to fund product development in preparation for the first human studies.
Hemideina is a Melbourne-based private company that is set to disrupt the cochlear implant market through its proprietary mechanical signal processing technology, the Hera wireless implant system. The company aims to provide a paradigm shift in hearing implant performance that will lead to increased access and adoption of treatment.
Oaklins’ team in Australia acted as lead manager in this transaction. The team has assisted Hemideina with fundraising since 2018 and is proud to support them on their mission to positively impact the lives of people with severe-to-profound hearing loss.
Elizabeth Williams
CEO and Co-founder, Hemideina
Talk to the deal team
Related deals
INNOTEX has been acquired by Clearspring Capital Partners
INNOTEX, a manufacturer of personal protective equipment for firefighters and first responders, has completed a strategic partnership with Clearspring Capital Partners.
Learn moreGARAIO has been acquired by Netrics Group
Netrics Group has acquired GARAIO AG as a wholly owned subsidiary. GARAIO will continue to operate as an independent company under the umbrella of Netrics Group. With this acquisition, Netrics Group is further expanding its leading position as a provider of managed cloud and digital workplace solutions as well as consulting services.
Learn moreAptic has received a minority investment from Sofiouest
The shareholders of Aptic have completed a primary minority LBO with Sofiouest.
Learn more